CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 281 filers reported holding CYTOKINETICS INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,485,206 | -8.7% | 118,303 | +1.0% | 0.68% | +6.6% |
Q2 2023 | $3,819,248 | +29.4% | 117,083 | +39.6% | 0.64% | +12.3% |
Q1 2023 | $2,950,682 | -22.8% | 83,850 | +0.5% | 0.57% | -23.4% |
Q4 2022 | $3,823,679 | -5.4% | 83,450 | 0.0% | 0.74% | -7.2% |
Q3 2022 | $4,043,000 | +22.5% | 83,450 | -0.7% | 0.80% | +19.8% |
Q2 2022 | $3,300,000 | +28.1% | 84,000 | +20.0% | 0.66% | +45.5% |
Q1 2022 | $2,577,000 | +1945.2% | 70,000 | +349.2% | 0.46% | +2946.7% |
Q1 2019 | $126,000 | +28.6% | 15,582 | 0.0% | 0.02% | +15.4% |
Q4 2018 | $98,000 | -35.9% | 15,582 | 0.0% | 0.01% | -18.8% |
Q3 2018 | $153,000 | – | 15,582 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |